A 1-Year Open-Label Safety Extension Study of Pregabalin in Patients With Anxiety Disorders
A 1-Year Open-Label Safety Extension Study of Pregabalin in Patients With Anxiety Disorders
Determine long-term safety and tolerability of pregabalin in patients with anxiety disorders.
Inclusion Criteria:
Exclusion Criteria:
A-1040 Wien, Austria
Wein, A-1020, Austria
Bad-Deurrheim, 78073, Germany
BV Losser, 7581, Netherlands
GC Nijmegen, 6525, Netherlands
RC Dordrecht, 3317, Netherlands
Zwigndrecht, 3333 EP, Netherlands
Zwijndreacht, 3334 XA, Netherlands
Hurlingham, Johannesburg, 2070, South Africa
Pinetown Natal, 3610, South Africa
Clarckston, Glasgow G76 7BX, United Kingdom
Greenisland, Carrickfergus, Northern Ireland BT38 8TP, United Kingdom
Epworth, Doncaster, South Yorkshire DN9 1EP, United Kingdom
Earlsdon, Coventry, CV5 6EU, United Kingdom